Lisa Crandall, M.S. - Vice President of Pharmaceutical Development
Lisa Crandall, M.S., PMP
With nearly two decades of experience in cGMP and GLP environments, Lisa serves as Vice President of Pharmaceutical Development at Velesco Pharmaceutical Services. Her pharmaceutical development experience and expertise spans from analytical method development and validation to toxicology formulations.
Lisa was formerly with the Pharmaceutical Sciences division of Pfizer Global Research & Development in Ann Arbor, Michigan, and served as a scientist in the drug development process, research analytical and supply chain analytical divisions. Her responsibilities and projects spanned the drug development spectrum from early stage development and validation of stability-indicating methods for the release of drug substance and drug product, to later stage projects focused on the detection of residual drugs on manufacturing equipment.
Lisa holds a Bachelor of Science degree from the University of Michigan and a Master of Science degree in Pharmaceutical Sciences from the University of Nebraska Medical Center. She holds a graduate certificate in Pharmaceutical Project Management from the University of Washington, and her Project Management Professional certification.
News and Events
New Velesco Pharma clinical manufacturing facility begins operations. Read the press release here.
Lisa Crandall, MS, and Peter Angus, PhD, spoke with Pharmaceutical Technology about the best practices in stability testing. Read the interview here.
Velesco has expanded our analytical facilities in a new Wixom, Michigan location with the help of the Bank of Ann Arbor Technology Industry Group. Read the press release here.
CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing!
2 new job postings! Careers
Velesco's work published
Formulation Development & Manufacturing:
Using a Single Provider Reduces Costs & Risk
Read it here.